Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05858879

Notification of Incidental Coronary Artery Calcium in Patients With Atherosclerotic Cardiovascular Disease (NOTIFY-ASCVD)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
233 (actual)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 84 Years
Healthy volunteers
Not accepted

Summary

Estimate the impact of notifying both patients and their clinicians of the presence of incidental coronary artery calcium (CAC) on initiation of lipid-lowering therapy in patients with ASCVD who are not receiving lipid-lowering therapy.

Detailed description

This is a randomized quality improvement (QI) project evaluating the impact of notifying patients and their clinicians (primary care, cardiologists, neurologists, or vascular surgeon) of incidental CAC detected on a prior chest CT scan. Patients will be identified by screening previous non-gated chest CT scans and electronic health records. The presence of CAC will be confirmed by a radiologist. Eligible patients will be randomized to: 1) notification of presence of CAC with a CT scan image; 2) notification of presence of CAC without a CT scan image; 3) or usual care.

Conditions

Interventions

TypeNameDescription
OTHERNotification of patients and cliniciansNotification Patients randomized to notification will receive a message sent by either the electronic health record (EHR) patient portal or US mail that will inform them of the CAC identified on their previous chest CT scan (with or without an image) and a recommendation that they discuss this finding and initiation of lipid-lowering therapy with their clinician. The clinicians will be notified of these findings by an earlier EHR message that will be sent 2 weeks before the patient notification. Two months after the initial notification, patients and their clinicians who are randomized to notification arms will receive a second message similar to the initial notification.

Timeline

Start date
2024-10-22
Primary completion
2026-09-01
Completion
2026-09-01
First posted
2023-05-15
Last updated
2025-11-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05858879. Inclusion in this directory is not an endorsement.